Union Square biotech raises $142M to use AI to build proteins
A Union Square biotech launched with $142 million in seed funds to use artificial intelligence to build proteins -- a process the firm says simulates 500 million years of natural e…
A Union Square biotech launched with $142 million in seed funds to use artificial intelligence to build proteins -- a process the firm says simulates 500 million years of natural e…